This content is from: Features

Canada's new takeover regime: Watch this space

Stikeman Elliott partners analyse Canada’s new takeover bid regime and its impact on Aurora’s recent hostile bid for competitor CanniMed

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial